Federated Hermes
PLSE icon

Federated Hermes’s Pulse Biosciences PLSE Stock Holding History

Federated Hermes’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.04M Buy
+160,965
New +$6.79M 0.01% 753
2017
Q4 		– Sell
-124
Closed -$2K – 2215
2017
Q3 		$2K Sell
124
-91
-42% -$2.07K ﹤0.01% 2051
2017
Q2 		$7K Buy
+215
New +$5.91K ﹤0.01% 1895

Other funds holding PLSE

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Griffin Asset Management
Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $189B AUM 37.1% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Federated Hermes's PLSE Position: Q3 2026 in Review

Federated Hermes opened a new position in Pulse Biosciences (PLSE) in Q3 2026: 160,965 shares worth $8.04M. The stake represents 0.01% of the portfolio and ranks #753 among its holdings. This is a return to the name: Federated Hermes previously reported a position in PLSE as recently as Q3 2017.

Federated Hermes first reported a position in PLSE in Q2 2017 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • Federated Hermes held 160,965 shares of Pulse Biosciences worth $8.04M as of Q3 2026.
  • Pulse Biosciences was a new Federated Hermes position in Q3 2026.
  • Pulse Biosciences made up 0.01% of Federated Hermes's portfolio in Q3 2026, its #753 holding.
  • Federated Hermes first reported a position in Pulse Biosciences in Q2 2017 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.